GSK256066 Chemical Structure
Rolipram is a PDE4-inhibitor and an anti-inflammatory agent.
Cilomilast (SB-207499) is among the first of a new generation of PDE4 inhibitors (Ki ≈100 nM).
Pimobendan (Vetmedin) is a selective inhibitor of phosphodiesterase III (PDE III) with an IC50 of 0.32 μM.
S-(+)-Rolipram is a less active enantiomer of the PDE4 inhibitor with an EC50 of 1.0 μM
PF-2545920 a highly selective and potent PDE10A inhibitor with an IC50 of 0.37 nM.
LY315920(Varespladib) is a sPLA2 inhibitor (IC50 of 9.6 ±1 nM)
Abiraterone (CB-7598) is a potent steroidal cytochrome P450 17alpha-hydroxylase-17,20-lyase (CYP17) inhibitor with an IC50 at 4 nM.
Bicalutamide (Casodex) is an active competitive non-steroidal androgen receptor antagonist.
Inhibitor of the 17,20 lyase.
MDV3100 (Enzalutamide) is androgen-receptor inhibitor. Highly recommended inhibitor in AR research.
GSK256066 is an exceptionally high affinity and selective PDE4 inhibitor with an IC50 of 3.2 pM for PDE4B. GSK256066 suppressed tumor necrosis factor α production by lipopolysaccharide (LPS)-stimulated human peripheral blood monocytes with 0.01 nM IC50 (compared with IC50 values of 5, 22, and 389 nM for roflumilast, tofimilast, and cilomilast, respectively) and by LPS-stimulated whole blood with 126 pM IC50. GSK256066 also inhibited LPS-induced increases in exhaled nitric oxide (ED50=35 µg/kg). In addition, GSK256066 prevented pulmonary eosinophilia in rats exposed to ovalbumin (ED50=0.4 μg/kg). In ferrets, inhaled GSK256066 inhibited LPS-induced pulmonary neutrophilia (ED50=18 μg/kg) and no emetic episodes were observed. [1][2]
| Molecular Weight (WM): | 518.58 |
|---|---|
| Formula: | C27H26N4O5S |
| CAS No.: | 801312-28-7 |
| Synonyms: |
N/A
|
| Dissolve in (25°C): | DMSO ≥5mg/mL |
| Water <1mg/mL | |
| Ethanol <1mg/mL | |
| Storage: | 2 years-20°CPowder |
| 1 week-4°Cin DMSO | |
| 1 month-80°in DMSO |
A collection of 864 bioactive compounds
A collection of 481 inhibitors
A collection of 194 kinase inhibitors
A collection of 85 tyrosine kinase inhibitors.
A collection of 426 FDA approved drugs
A collection of 139 natural products
A collection of 40 chemotherapeutic agents
A unique collection of 17 small molecule modulators
A unique collection of 47 small molecule inhibitors
A unique collection of 63 GPCR small molecules
Keywords:buy GSK256066 | GSK256066 supplier | purchase GSK256066 | GSK256066 cost | GSK256066 manufacturer | order GSK256066 | GSK256066 distributor